Literature DB >> 8674326

Gastrointestinal permeability and absorptive capacity in sepsis.

J D Johnston1, C J Harvey, I S Menzies, D F Treacher.   

Abstract

OBJECTIVE: To assess gastrointestinal permeability and functional absorptive capacity in patients with sepsis.
DESIGN: Case control study to analyze gastrointestinal permeability and functional absorptive capacity of septic patients by differential saccharide absorption (from an oral test solution) and excretion.
SETTING: The intensive Therapy Unit of St. Thomas' Hospital, London, UK. PATIENTS: Twenty patients with a mean Acute Physiology and Chronic Health Evaluation (APACHE) II score of 18.4 who were admitted to the intensive care unit with a diagnosis of sepsis. All patients were on enteral feeding. Patients with abdominal pathology were excluded.
INTERVENTIONS: An oral test solution containing 5 g of lactulose, 1 g of L-rhamnose, 0.5 g of D-xylose, and 0.2 g of 3-O-methyl-D-glucose dissolved in water to a final volume of 100 mL was administered to patients and controls. Urine was collected for 5 hrs starting immediately after administration of the test solution and the saccharide content of the urine was estimated and expressed as a percentage recovery of the oral test solution.
MEASUREMENTS AND MAIN RESULTS: Septic patients had increased lactulose/L-rhamnose urine excretion ratios (0.23 +/- 0.19) compared with control subjects (0.03 +/- 0.01, p < .001), consistent with increased gastrointestinal permeability in sepsis. Septic patients had decreased L-rhamnose/3-O-methyl-D-glucose urine excretion ratios (0.14 +/- 0.07) compared with normal controls (0.28 +/- 0.08, p < .001), consistent with decreased gastrointestinal functional absorptive capacity in sepsis.
CONCLUSIONS: Patients with acute sepsis exhibit increased gastrointestinal permeability and decreased gastrointestinal functional absorptive capacity in comparison with healthy control subjects. These abnormalities may contribute to the pathophysiology of sepsis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8674326     DOI: 10.1097/00003246-199607000-00013

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  16 in total

1.  Intestinal epithelium is more susceptible to cytopathic injury and altered permeability than the lung epithelium in the context of acute sepsis.

Authors:  Mark W Julian; Shengying Bao; Daren L Knoell; Ruairi J Fahy; Guohong Shao; Elliott D Crouser
Journal:  Int J Exp Pathol       Date:  2011-08-13       Impact factor: 1.925

2.  Lack of correlation between failure of gut barrier function and septic complications after major upper gastrointestinal surgery.

Authors:  S Kanwar; A C Windsor; F Welsh; G R Barclay; P J Guillou; J V Reynolds
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

3.  A randomised, double-blinded, placebo-controlled, pilot study of parenteral glutamine for allogeneic stem cell transplant patients.

Authors:  N M A Blijlevens; J P Donnelly; A H J Naber; A V M B Schattenberg; B E DePauw
Journal:  Support Care Cancer       Date:  2005-03-15       Impact factor: 3.603

Review 4.  Monitoring the hepato-splanchnic region in the critically ill patient. Measurement techniques and clinical relevance.

Authors:  A Brinkmann; E Calzia; K Träger; P Radermacher
Journal:  Intensive Care Med       Date:  1998-06       Impact factor: 17.440

5.  Lactobacillus plantarum 299v inhibits Escherichia coli-induced intestinal permeability.

Authors:  Peter Mangell; Pernilla Nejdfors; Mei Wang; Siv Ahrné; Bjorn Weström; Henrik Thorlacius; Bengt Jeppsson
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

6.  Glutamine supplementation of parenteral nutrition does not improve intestinal permeability, nitrogen balance, or outcome in newborns and infants undergoing digestive-tract surgery: results from a double-blind, randomized, controlled trial.

Authors:  Marcel J I J Albers; Ewout W Steyerberg; Frans W J Hazebroek; Marjan Mourik; Gerard J J M Borsboom; Trinet Rietveld; Jan G M Huijmans; Dick Tibboel
Journal:  Ann Surg       Date:  2005-04       Impact factor: 12.969

7.  Increased Small Intestinal Permeability during Severe Acute Exacerbations of COPD.

Authors:  Roy T M Sprooten; Kaatje Lenaerts; Dionne C W Braeken; Ilvy Grimbergen; Erica P Rutten; Emiel F M Wouters; Gernot G U Rohde
Journal:  Respiration       Date:  2018-01-25       Impact factor: 3.580

8.  Mesenteric blood flow, glucose absorption and blood pressure responses to small intestinal glucose in critically ill patients older than 65 years.

Authors:  Jennifer A Sim; M Horowitz; M J Summers; L G Trahair; R S Goud; A V Zaknic; T Hausken; J D Fraser; M J Chapman; K L Jones; A M Deane
Journal:  Intensive Care Med       Date:  2012-10-25       Impact factor: 17.440

9.  Differential expression of Toll-like receptor (TLR)-2 and TLR-4 on monocytes in human sepsis.

Authors:  L Armstrong; A R L Medford; K J Hunter; K M Uppington; A B Millar
Journal:  Clin Exp Immunol       Date:  2004-05       Impact factor: 4.330

Review 10.  Is There a Role for the Enteral Administration of Serum-Derived Immunoglobulins in Human Gastrointestinal Disease and Pediatric Critical Care Nutrition?

Authors:  Melissa Van Arsdall; Ikram Haque; Yuying Liu; J Marc Rhoads
Journal:  Adv Nutr       Date:  2016-05-16       Impact factor: 8.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.